A dose-escalation clinical trial of intranasal ketamine for uncontrolled cancer-related pain.
Singh V, Gillespie TW, Lane O, Spektor B, Zarrabi AJ, Egan K, Curseen K, Tsvetkova M, Beumer JH, Sniecinski R, Shteamer JW, Switchenko J, Harvey RD.
Singh V, et al. Among authors: gillespie tw.
Pharmacotherapy. 2022 Apr;42(4):298-310. doi: 10.1002/phar.2669. Epub 2022 Feb 21.
Pharmacotherapy. 2022.
PMID: 35146776
Free PMC article.